Alzheimer’s disease (AD) accounts for about 70% of neurodegenerative diseases and is a cause of cognitive decline and death for one-third
Alzheimer’s disease (AD) accounts for about 70% of neurodegenerative diseases and is a cause of cognitive decline and death for one-third of seniors. AD is currently underdiagnosed, and it cannot be effectively prevented. Aggregation of amyloid-β (Aβ) proteins has been linked to the development of AD, and it has been established that, under pathological conditions, Aβ proteins undergo structural changes to form β-sheet structures that are considered neurotoxic. Numerous intensive in vitro studies have provided detailed information about amyloid polymorphs; however, little is known on how amyloid β-sheet-enriched aggregates can cause neurotoxicity in relevant settings. We used scattering-type scanning near-field optical microscopy (s-SNOM) to study amyloid structures at the nanoscale, in individual neurons. Specifically, we show that in well-validated systems, s-SNOM can detect amyloid β-sheet structures with nanometer spatial resolution in individual neurons. This is a proof-of-concept study to demonstrate that s-SNOM can be used to detect Aβ-sheet structures on cell surfaces at the nanoscale. Furthermore, this study is intended to raise neurobiologists’ awareness of the potential of s-SNOM as a tool for analyzing amyloid β-sheet structures at the nanoscale in neurons without the need for immunolabeling
Lund University, Faculty of Medicine, Department of Experimental Medical Science, Medical Microspectroscopy, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Medicinsk mikrospektroskopi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Neuroinflammation, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Neuroinflammation, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Experimental Dementia Research, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Experimentell demensforskning, Originator, Lund University, Faculty of Science, Department of Physics, Solid State Physics, Lunds universitet, Naturvetenskapliga fakulteten, Fysiska institutionen, Fasta tillståndets fysik, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Originator, Lund University, Faculty of Science, LINXS - Institute of advanced Neutron and X-ray Science, Lunds universitet, Naturvetenskapliga fakulteten, LINXS Institute of advanced Neutron and X-ray Science, Originator